$NUKK
Nukkleus Inc. Stock $nukk

$nukk Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022072214 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$5.431M	$5.602M	$5.460M
YoY Change	-5.25%	2.6%	15.55%
Gross Profit	-$54.87K	$541.7K	-$614.3K
YoY Change	-90.91%	-188.18%	-919.07%
Gross Profit Margin
Selling, General & Admin	$1.015M	$1.855M	$285.0K
YoY Change	-20.36%	550.98%	270.73%
% of Gross Profit		342.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$592.9K	$592.9K	$352.1K
YoY Change	-34.99%	68.37%
% of Gross Profit		109.45%
Operating Expenses	$107.7K	$480.9K	$153.3K
YoY Change	-73.78%	213.6%	224.46%
Operating Profit	-$162.5K	-$480.9K	-$153.3K
YoY Change	-83.97%	213.6%	-652.76%
Interest Expense	$214.6K	-$97.89K	$28.73K
YoY Change	-1066.85%	-440.72%	1505.03%
% of Operating Profit
Other Income/Expense, Net	$2.570K	-$97.89K	$28.73K
YoY Change	-310.66%	-440.76%	-5139.65%
Pretax Income	$107.0K	-$578.8K	-$124.6K
YoY Change	-124.72%	364.45%	173.99%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$107.0K	-$578.8K	-$124.6K
YoY Change	-124.72%	364.45%	173.99%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.11	-$0.13	-$0.02
Diluted Earnings Per Share	$0.02	-$0.13	-$20.39K
COMMON SHARES
Basic Shares Outstanding	2.076M shares	4.452M shares	6.111M shares
Diluted Shares Outstanding	10.07M shares	4.539M shares	6.111M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.111M	$31.20M	$47.43M
YoY Change	-87.18%	-34.22%	1.21%
Cash & Equivalents	$6.111M	$31.20M	$504.4K
Short-Term Investments			$46.93M
Other Short-Term Assets	$740.00	$51.98K	$22.26K
YoY Change	-99.97%	133.51%
Inventory
Prepaid Expenses
Receivables	$102.8K	$35.00K	$57.95K
Other Receivables	$0.00	$931.1K	$0.00
Total Short-Term Assets	$6.112M	$31.25M	$47.45M
YoY Change	-87.18%	-34.14%	1.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.602M	$6.602M
YoY Change	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$6.112M	$31.25M	$47.45M
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$6.112M	$31.25M	$47.45M
YoY Change	-87.18%	-34.14%	1.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$315.0K	$336.8K	$142.7K
YoY Change	1.75%	136.07%	143.75%
Accrued Expenses	$424.9K	$436.4K	$0.00
YoY Change			-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$3.651M	$3.483M	$1.165M
YoY Change	124.62%	199.02%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.966M	$3.820M	$1.308M
YoY Change	104.96%	192.14%	262.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.64K	$225.3K	$157.1K
YoY Change	-94.1%	43.38%
Total Long-Term Liabilities	$10.64K	$225.3K	$157.1K
YoY Change	-94.1%	43.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.966M	$3.820M	$1.308M
Total Long-Term Liabilities	$10.64K	$225.3K	$157.1K
Total Liabilities	$3.976M	$4.045M	$1.465M
YoY Change	87.98%	176.19%	306.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.800M	-$7.839M
YoY Change	36.55%
Common Stock	$3.880M	$3.880M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.920M	-$3.959M	$45.99M
YoY Change
Total Liabilities & Shareholders Equity	$6.112M	$31.25M	$47.45M
YoY Change	-87.18%	-34.14%	1.26%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	$107.0K	-$578.8K	-$124.6K
YoY Change	-124.72%	364.45%	173.99%
Depreciation, Depletion And Amortization	$592.9K	$592.9K	$352.1K
YoY Change	-34.99%	68.37%
Cash From Operating Activities	-$78.25K	-$140.7K	-$122.6K
YoY Change	-64.82%	14.81%	-1187.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$41.49M	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	$41.49M	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-25.01M	-10.19M	0.000
YoY Change	-1910.57%		-100.0%
NET CHANGE
Cash From Operating Activities	-78.25K	-140.7K	-122.6K
Cash From Investing Activities	0.000	41.49M	0.000
Cash From Financing Activities	-25.01M	-10.19M	0.000
Net Change In Cash	-25.09M	31.16M	-122.6K
YoY Change	11256.1%	-25522.08%	175014.29%
FREE CASH FLOW
Cash From Operating Activities	-$78.25K	-$140.7K	-$122.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39341
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
	dei	Entity Address Address Line1 EntityAddressAddressLine1	99 Dan Ba Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	C-9
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Putuo District
	dei	Entity Address City Or Town EntityAddressCityOrTown	Shanghai
	dei	Entity Address Country EntityAddressCountry	CN
	dei	City Area Code CityAreaCode	(86)
	dei	Local Phone Number LocalPhoneNumber	021-80125497
	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value per share
	dei	Trading Symbol TradingSymbol	BRLI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2075936	shares
CY2022Q3	us-gaap	Cash Cash	31202110	usd
CY2021Q4	us-gaap	Cash Cash	283403	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	51976	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	47387687	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	31254086	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	47671090	usd
CY2022Q3	us-gaap	Assets Assets	31254086	usd
CY2021Q4	us-gaap	Assets Assets	47671090	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	336842	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	309597	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	870600	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	500	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2612427	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1624833	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3819869	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1934930	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	225280	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	180479	usd
CY2022Q3	us-gaap	Liabilities Liabilities	4045149	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2115409	usd
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2940927	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4600000	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31168066	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	47387687	usd
CY2021Q4	brli	Preferred Stock Shares Authorized Unlimited Shares PreferredStockSharesAuthorizedUnlimitedShares	unlimited
CY2022Q3	brli	Preferred Stock Shares Authorized Unlimited Shares PreferredStockSharesAuthorizedUnlimitedShares	unlimited
CY2021Q4	brli	Common Stock Shares Authorized Unlimited Share CommonStockSharesAuthorizedUnlimitedShare	unlimited
CY2022Q3	brli	Common Stock Shares Authorized Unlimited Share CommonStockSharesAuthorizedUnlimitedShare	unlimited
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1511000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1511000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1511000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1511000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3880288	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3880288	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7839417	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5712294	usd
	brli	Redemption Of Share RedemptionOfShare	633792	shares
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-52704	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3019078	usd
	brli	Less Redemption Of Shares LessRedemptionOfShares	6529259	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-578753	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28726	usd
CY2022Q3	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-353000	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-8298	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3959129	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1074579	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	44801	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-90517	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	8298	usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	1177	usd
	us-gaap	Interest Income Other InterestIncomeOther	64950	usd
	us-gaap	Interest Income Other InterestIncomeOther	3469	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-97886	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3959129	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1832006	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31254086	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47671090	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	480867	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	153337	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1094728	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	260315	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-480867	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-153337	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1094728	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-260315	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	106184	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-27549	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20149	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	93986	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-578753	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-124611	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1074579	usd
	us-gaap	Net Income Loss NetIncomeLoss	-166329	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4539123	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6111000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5342708	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6111000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	154808	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-20373	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	134435	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-21345	usd
CY2021Q2	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-460000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-346910	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-124611	usd
CY2021Q3	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-460000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-931521	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1832006	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	712817	usd
	us-gaap	Net Income Loss NetIncomeLoss	-166329	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31202110	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-460282	usd
CY2022Q1	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-634594	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-3948	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-2930830	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-35544	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	283403	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	44801	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-90517	usd
	brli	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount	3469	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	51976	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6637	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	27245	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	58497	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1054509	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-208455	usd
	brli	Proceeds From Sale Of Investment Of Cash In Trust Account ProceedsFromSaleOfInvestmentOfCashInTrustAccount	47387687	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	47387687	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	987594	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	870100	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	17272165	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15414471	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	30918707	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-208455	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	504362	usd
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P180D
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	2069154	usd
	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1610000	usd
	brli	Other Offering Cost OtherOfferingCost	459154	usd
CY2022Q3	us-gaap	Investments And Cash InvestmentsAndCash	34044	usd
CY2022Q3	brli	Fair Market Value Percentage FairMarketValuePercentage	0.80	pure
	brli	Redeemption Percent RedeemptionPercent	1	pure
	us-gaap	Other Expenses OtherExpenses	50000	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	34044	usd
CY2022Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	909424	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	7687	usd
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	1380000	usd
CY2021Q4	brli	Ordinary Shares Subject To Possible Redemption1 OrdinarySharesSubjectToPossibleRedemption1	47387687	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	brli	Cash And Noncash Equivalents CashAndNoncashEquivalents	34044	usd
CY2021	brli	Cash And Noncash Equivalents CashAndNoncashEquivalents	283403	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	47387687	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	633792	shares
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1025281	shares
	brli	Subject To Possible Redemption SubjectToPossibleRedemption	2940927	shares
CY2021	brli	Subject To Possible Redemption SubjectToPossibleRedemption	4600000	shares
	brli	Common Stock Per Share CommonStockPerShare	10
CY2020Q4	brli	Ordinary Shares Subject To Possible Redemption1 OrdinarySharesSubjectToPossibleRedemption1	46000000	usd
CY2019Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
	brli	Redemption Of Share1 RedemptionOfShare1	1025281	shares
	brli	Less Redemption Of Shares1 LessRedemptionOfShares1	10742905	shares
	brli	Add Accretion Of Carrying Value To Redemption Value AddAccretionOfCarryingValueToRedemptionValue	64949	shares
	brli	Reclassifications Of Temporary To Permanent Equity1 ReclassificationsOfTemporaryToPermanentEquity1	987594	shares
CY2022Q3	brli	Ordinary Shares Subject To Possible Redemption1 OrdinarySharesSubjectToPossibleRedemption1	31168066	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-578753	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-124611	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1074579	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-166329	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4539123	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6111000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5342708	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6111000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2019Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	The initial shareholders have agreed not to transfer, assign or sell any of the Founder Shares (except to certain permitted transferees) until, the earlier of (i) one year after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, , or earlier, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.
	brli	Public Per Share Outstanding PublicPerShareOutstanding	0.04
	brli	Business Acquisition Description Of Trust Account BusinessAcquisitionDescriptionOfTrustAccount	On September 21, 2021, the Company issued an unsecured promissory note to our sponsor (the “Promissory Note III”), pursuant to which we could borrow up to an aggregate principal amount of $461,000, of which $461,000 was outstanding under the Promissory Note III as of June 30, 2022.
CY2021Q4	brli	Trust Account Management Expense TrustAccountManagementExpense	1000	usd
CY2021Q4	us-gaap	Securities Borrowed Increase SecuritiesBorrowedIncrease	460500	usd
CY2022Q1	brli	Trust Account Management Expense TrustAccountManagementExpense	500	usd
CY2022Q1	brli	Debt Outstanding Amount DebtOutstandingAmount	736000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Assets Expected To Be Returned To Employer Amount DefinedBenefitPlanAssetsExpectedToBeReturnedToEmployerAmount	101406	usd
CY2022Q1	brli	Aggregate Of Shares AggregateOfShares	633792	shares
	brli	Aggregate Price Per Share AggregatePricePerShare	10.48
CY2022Q3	us-gaap	Deposits Deposits	22600	usd
	brli	Aggregate Amount Shares AggregateAmountShares	2375991	shares
CY2022Q3	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	25180851	usd
	brli	Aggregate Amount Per Shares AggregateAmountPerShares	10.6
	brli	Working Capital WorkingCapital	870600	usd
	us-gaap	Direct Operating Costs DirectOperatingCosts	870100	usd
	brli	Registration Rights Description RegistrationRightsDescription	Notwithstanding the foregoing, EarlyBirdCapital, Inc. (“EarlyBirdCapital”) may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
CY2022Q3	brli	Cash Fee Equal Percentage CashFeeEqualPercentage	0.01	pure
CY2020Q2	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1511000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1511000	shares
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2940927	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4600000	shares
CY2022Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	261000	shares
CY2022Q3	us-gaap	Increase Decrease In Fair Value Of Price Risk Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1	106184	usd
	brli	Expected Life Of The Warrants To Converts ExpectedLifeOfTheWarrantsToConverts	P5Y1M24D
CY2021Q4	us-gaap	Share Price SharePrice	10.2
CY2021Q3	us-gaap	Increase Decrease In Fair Value Of Price Risk Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1	27549	usd
	us-gaap	Increase Decrease In Fair Value Of Price Risk Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1	44801	usd
	us-gaap	Increase Decrease In Fair Value Of Price Risk Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1	90517	usd
	brli	Volatility Volatility	0.0214	pure
CY2021	brli	Volatility Volatility	0.105	pure
CY2022Q3	us-gaap	Share Price SharePrice	10.57
CY2021	brli	Expected Life Of The Warrants To Converts ExpectedLifeOfTheWarrantsToConverts	P5Y6M21D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0413	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	247634	usd
CY2021Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-56901	usd
CY2021Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	190733	usd
CY2021Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-6067	usd
CY2021Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	184666	usd
CY2021Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-27549	usd
CY2021Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	157117	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	180479	usd
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-5041	usd
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	175438	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-56342	usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	119096	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	106184	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	225280	usd
CY2022Q3	us-gaap	Deposits Deposits	22600	usd
	brli	Aggregate Amount Shares AggregateAmountShares	2375991	shares
CY2022Q3	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	25180851	usd
	brli	Aggregate Amount Per Shares AggregateAmountPerShares	10.6
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	brli	Proceeds From Sale Of Investment Of Cash In Trust Account ProceedsFromSaleOfInvestmentOfCashInTrustAccount		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
	dei	Entity Central Index Key EntityCentralIndexKey	0001787518

Files In Submission

Name	View Source	Status
0001213900-22-072214-index-headers.html	Edgar Link	pending
0001213900-22-072214-index.html	Edgar Link	pending
0001213900-22-072214.txt	Edgar Link	pending
0001213900-22-072214-xbrl.zip	Edgar Link	pending
brli-20220930.xsd	Edgar Link	pending
f10q0922ex31-1_brilliantacq.htm	Edgar Link	pending
f10q0922ex31-2_brilliantacq.htm	Edgar Link	pending
f10q0922ex32-1_brilliantacq.htm	Edgar Link	pending
brli-20220930_cal.xml	Edgar Link	unprocessable
brli-20220930_def.xml	Edgar Link	unprocessable
brli-20220930_lab.xml	Edgar Link	unprocessable
f10q0922_brilliantacq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
f10q0922_brilliantacq_htm.xml	Edgar Link	completed
brli-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NUKK
Nukkleus Inc. Stock $nukk

2022 Q4 Form 10-Q Financial Statement

#000121390022072214 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUKK Nukkleus Inc. Stock $nukk

2022 Q4 Form 10-Q Financial Statement

#000121390022072214 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUKK
Nukkleus Inc. Stock $nukk